Contracts & Pricing March 13, 2025 Considerations for Branded Prescription Drug Fees 2 Minute Read Keep up-to-date on Branded Prescription Drug Fees with this summary of critical insights from Nick Lynch, Partner at IntegriChain, covering key deadlines and factors.
Contracts & Pricing March 4, 2025 Navigating Fair Market Value and Bona Fide Service Fees in 2024/2025:... 4 Minute Read In this blog, we recap the key insights shared by Nick Lynch, Partner at IntegriChain, and Suriya Janarthanan, Associate Director at Novartis, on how manufacturers can navigate FMV and...
Contracts & Pricing February 28, 2025 Build a Next-Generation Commercial Data Strategy with AI & ML 2 Minute Read In today’s rapidly evolving pharmaceutical landscape, creating an effective commercial data strategy is critical for achieving success.
Contracts & Pricing December 20, 2024 Navigating DSCSA Requirements with Compliance Solutions & Software 4 Minute Read As the industry approaches full compliance with DSCSA requirements, new challenges emerge, particularly in managing data discrepancies, addressing inventory exceptions, and navigating gross-to-net impacts.
Contracts & Pricing October 31, 2024 Industry Shifts: A Closer Look at Recent CMS and J&J Announcements 3 Minute Read Read the latest on the CMS September Final Rule Overview & a Controversial 340B Rebate Policy
Contracts & Pricing September 4, 2024 $35 Patient Out-of-Pocket Strategy: Impacts on Prescription Drug Affordability & Implications... 3 Minute Read Katie Herrick and Dan Landis, consultants from Blue Fin Group, discuss how pharmaceutical companies are adapting to the changing healthcare environment by focusing on improving patient access and affordability.
Contracts & Pricing September 4, 2024 Key Developments in Pharmaceutical Pricing Regulations 4 Minute Read Nick Lynch, Partner of Federal Compliance Solutions (FCS) discusses insights into recent developments in pharmaceutical pricing, focusing on government programs like 340B, Medicaid Drug Rebate Program (MDRP), Medicare Part...
Contracts & Pricing June 12, 2024 The Wild Ride of Medicare Part D Payer Challenges on Expenditures... 3 Minute Read Learn about the IRA's changes to Part D benefits have created uncertainty for both manufacturers and payers.
Contracts & Pricing April 24, 2024 Changing Pharmacy Reimbursements with CVS, FSS/IFF Reporting Alert & the Latest... 3 Minute Read Discover the latest on the Pharmacy Reimbursements for CVS, FSS/IFF Reporting Alert, and the 340B Drug Discount Program.
